• <i id="smq01"></i>
          <wbr id="smq01"></wbr>
          <source id="smq01"></source>
          ×

          01/01

          Tonghua Dongbao has been persistent in continuous product innovation. The constant optimization of the product mix for diabetes treatment has enabled us to keep strengthening our market competitiveness and lead the domestic industry.

          About Us

          Tonghua Dongbao developed China's first recombinant human insulin, with a trade name of Gansulin, in 1998. As the first of its kind in China, Gansulin helped China overcome years of dependence on imports of the medicine. This achievement won the second prize of the National Science and Technology Progress Award and was listed in the "Top 10 Scientific Breakthroughs 1998". Let’s get a glimpse into Tonghua Dongbao from the following figures.

          • 1985

            Year of founding

          • RMB 30.75bn

            Realize operating income (2023)

          • 387+

            Number of R&D staff

          • 26+

            Categories of popular products

          久久一级片|亚洲国产精品无码二区|天天在线精品视频一区二区|丁香色婷婷国产精品视频

        1. <i id="smq01"></i>
                <wbr id="smq01"></wbr>
                <source id="smq01"></source>